Chemomab Therapeutics Ltd. (CMMB)
$2.17+0.46%Close
BUYRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $13M
- Avg volume
- 105.6K
- Beta
- 0.66
- P/E (TTM)
- -2.12
- Short % float
- 2.81%
- Days to cover
- 2.2
- SI change
- +15.3%
- 1W
- +13.02%
- 1M
- +59.56%
- 3M
- +7.43%
- YTD
- +21.23%
- vs SPY 1W
- +14.21%
- vs SPY 1M
- +56.24%
- vs SPY 3M
- +5.03%
- vs SPY YTD
- +9.48%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- IKTBUYInhibikase Therapeutics, Inc.BULLQ -20$2.50+4.60%
- MAIABUYMAIA Biotechnology, Inc.RECOVERYQ -7$1.35-2.88%
- MSLEBUYSatellos Bioscience Inc. Common StockBEARQ 7$9.47-5.39%
- OKYOSELLOKYO Pharma LimitedRECOVERYQ 0$1.50-2.60%
- PTPIBUYPetros Pharmaceuticals, Inc.RECOVERYQ -27$0.00
- MXCTBUYMaxCyte, Inc.RECOVERYQ 13$1.39+0.72%
- XTNTSELLXtant Medical Holdings, Inc.CRISISQ -7$0.32+0.00%
- ICUSELLSeaStar Medical Holding CorporationRECOVERYQ -28$3.19-4.78%
- AKTSBUYAktis Oncology, Inc.Q 31$25.98+7.94%
- ALGSBUYAligos Therapeutics, Inc.RECOVERYQ -21$6.93+3.90%
- ANEBBUYAnebulo Pharmaceuticals, Inc.CRISISQ -4$0.31-6.06%
- HTFLBUYHeartflow, Inc. Common StockRECOVERYQ 46$50.20+0.90%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 11
- VALUE
- 5
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-42.5%
REV YoY-
ROE-70.8%
EPS YoY-
ROA-74.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-2.12
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B2.00
P/FCF-
EV/EBITDA-0.93
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO6.41
ND/EBITDA-
BETA0.66
